rs1554810215
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001114753.3(ENG):c.808C>T(p.Gln270*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001114753.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.808C>T | p.Gln270* | stop_gained | Exon 6 of 15 | ENST00000373203.9 | NP_001108225.1 | |
ENG | NM_000118.4 | c.808C>T | p.Gln270* | stop_gained | Exon 6 of 14 | NP_000109.1 | ||
ENG | NM_001278138.2 | c.262C>T | p.Gln88* | stop_gained | Exon 6 of 15 | NP_001265067.1 | ||
ENG | NM_001406715.1 | c.808C>T | p.Gln270* | stop_gained | Exon 6 of 8 | NP_001393644.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.808C>T | p.Gln270* | stop_gained | Exon 6 of 15 | 1 | NM_001114753.3 | ENSP00000362299.4 | ||
ENG | ENST00000344849.4 | c.808C>T | p.Gln270* | stop_gained | Exon 6 of 14 | 1 | ENSP00000341917.3 | |||
ENG | ENST00000480266.6 | c.262C>T | p.Gln88* | stop_gained | Exon 6 of 15 | 2 | ENSP00000479015.1 |
Frequencies
GnomAD3 genomes Cov.: 27
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 27
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 1 Pathogenic:3
- -
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with hereditary haemorrhagic telangiectasia type 1 (HHT; MIM#187300). Multiple pathogenic null variants have been reported, and missense variants have been demonstrated to have both loss of function and dominant negative effects on protein activity (PMIDs: 25080347, 25312062). (I). 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other null variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. There are multiple likely pathogenic and pathogenic NMD-predicted variants that have been reported (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in at least five individuals or families with hereditary haemorrhagic telangiectasia (ClinVar, PMIDs: 24001356, 29483005, 31455059). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Hereditary hemorrhagic telangiectasia Pathogenic:2
Loss-of-function variants in ENG are known to be pathogenic (PMID: 21158752, 12673790). For these reasons, this variant has been classified as Pathogenic. This variant has been reported to segregate with hemorrhagic telangiectasia in a family (PMID: 24001356). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln270*) in the ENG gene. It is expected to result in an absent or disrupted protein product. -
This sequence change in ENG is a nonsense variant predicted to cause a premature stop codon, p.(Gln270*), in biologically relevant exon 6/15 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PMID: 20301525). This variant is absent from population database gnomAD v2.1 and v3.1. This variant has been reported in at least three probands with a clinical diagnosis of hereditary haemorrhagic telangiectasia and segregates with disease (PMID: 24001356, 31455059, 32300199). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PS4_Moderate, PM2_Supporting, PP1. -
not provided Pathogenic:1
The ENG c.808C>T; p.Gln270Ter variant is reported in the literature in a family affected with HHT (Torring 2014). This variant is also reported as pathogenic in ClinVar (Variation ID: 458355), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, Genome Aggregation Database). This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA that is subject to nonsense medicated decay. Based on the above information, this variant is considered pathogenic. REFERENCES Torring PM et al. National mutation study among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2014 Aug;86(2):123-33. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at